AYTU BIOPHARMA, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $128.1M | $265.7M | $49.6M |
| FY2022 | $93.3M | $137.6M | $19.4M |
| FY2023 | $97.1M | $136.5M | $23.0M |
| FY2024 | $90.4M | $118.1M | $20.0M |
| FY2025 | $105.2M | $124.2M | $31.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $128.1M | $265.7M | $49.6M |
| FY2022 | $93.3M | $137.6M | $19.4M |
| FY2023 | $97.1M | $136.5M | $23.0M |
| FY2024 | $90.4M | $118.1M | $20.0M |
| FY2025 | $105.2M | $124.2M | $31.0M |